CRT Capital Increases LifePoint Hospitals Price Target to $63.50 (LPNT)
Investment analysts at CRT Capital lifted their price objective on shares of LifePoint Hospitals (NASDAQ:LPNT) from $60.00 to $63.50 in a note issued to investors on Monday, American Banking News reports. The firm currently has a “buy” rating on the stock. CRT Capital’s target price indicates a potential upside of 11.66% from the company’s current price.
Shares of LifePoint Hospitals (NASDAQ:LPNT) traded up 1.23% on Monday, hitting $57.57. 255,273 shares of the company’s stock traded hands. LifePoint Hospitals has a one year low of $43.97 and a one year high of $57.13. The stock has a 50-day moving average of $52.96 and a 200-day moving average of $52.18. The company has a market cap of $2.561 billion and a price-to-earnings ratio of 20.46.
LifePoint Hospitals (NASDAQ:LPNT) last released its earnings data on Friday, April 25th. The company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.13. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1,000.00 million. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. On average, analysts predict that LifePoint Hospitals will post $2.66 earnings per share for the current fiscal year.
LPNT has been the subject of a number of other recent research reports. Analysts at Bank of America reiterated a “neutral” rating on shares of LifePoint Hospitals in a research note on Monday. They now have a $65.00 price target on the stock. Separately, analysts at RBC Capital raised their price target on shares of LifePoint Hospitals from $62.00 to $63.00 in a research note on Monday. They now have an “outperform” rating on the stock. Finally, analysts at Mizuho raised their price target on shares of LifePoint Hospitals from $54.00 to $58.00 in a research note on Monday. They now have a “neutral” rating on the stock. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have given a buy rating to the company’s stock. LifePoint Hospitals currently has an average rating of “Hold” and an average price target of $57.12.
LifePoint Hospitals, Inc (NASDAQ:LPNT), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.